MIR4311

Across TCGA pan-cancer cohorts, MIR4311 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MIR4311 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MIR4311 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4311 expression acts as an unfavorable survival marker, although some lineages such as BRCA show a favorable association.

BLCA, UCS, and LIHC are the cancer types where MIR4311 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.218	0.722	<.001	90	view →
UCS	DFS	Tertile	III,IV	0.138	0.451	.004	72	view →
LIHC	DFS	Tertile	All	0.108	0.545	<.001	63	view →
STAD	DFS	Tertile	All	0.512	0.672	.015	45	view →
THCA	OS	Tertile	II,III,IV	0.843	0.987	.010	27	view →
UVM	OS	Tertile	All	0.292	0.674	.035	18	view →
BRCA	DFS	Tertile	All	1.000	0.519	.034	12	view →
SKCM	OS	Tertile	III,IV	0.216	0.721	.001	9	view →
PAAD	OS	Tertile	All	0.444	0.605	.046	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MIR4311–BLCA (OS)

Open the BLCA breakdown →